- Home
- CMMB vs ARTW Comparison
CMMB vs ARTW Comparison
Compare CMMB & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ARTW
- Stock Information
- Founded
- CMMB 2004
- ARTW 1956
- Country
- CMMB Israel
- ARTW United States
- Employees
- CMMB N/A
- ARTW N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ARTW Industrial Machinery/Components
- Sector
- CMMB Health Care
- ARTW Industrials
- Exchange
- CMMB Nasdaq
- ARTW Nasdaq
- Market Cap
- CMMB 13.7M
- ARTW 15.3M
- IPO Year
- CMMB N/A
- ARTW N/A
- Fundamental
- Price
- CMMB $3.28
- ARTW $2.63
- Analyst Decision
- CMMB Strong Buy
- ARTW
- Analyst Count
- CMMB 2
- ARTW 0
- Target Price
- CMMB $26.50
- ARTW N/A
- AVG Volume (30 Days)
- CMMB 260.4K
- ARTW 31.0K
- Earning Date
- CMMB 11-13-2025
- ARTW 10-07-2025
- Dividend Yield
- CMMB N/A
- ARTW N/A
- EPS Growth
- CMMB N/A
- ARTW N/A
- EPS
- CMMB N/A
- ARTW 0.49
- Revenue
- CMMB N/A
- ARTW $24,079,949.00
- Revenue This Year
- CMMB N/A
- ARTW N/A
- Revenue Next Year
- CMMB N/A
- ARTW N/A
- P/E Ratio
- CMMB N/A
- ARTW $7.51
- Revenue Growth
- CMMB N/A
- ARTW N/A
- 52 Week Low
- CMMB $2.39
- ARTW $1.43
- 52 Week High
- CMMB $9.84
- ARTW $4.71
- Technical
- Relative Strength Index (RSI)
- CMMB 59.76
- ARTW 43.55
- Support Level
- CMMB $3.03
- ARTW $2.82
- Resistance Level
- CMMB $3.50
- ARTW $3.14
- Average True Range (ATR)
- CMMB 0.21
- ARTW 0.26
- MACD
- CMMB 0.02
- ARTW 0.02
- Stochastic Oscillator
- CMMB 64.21
- ARTW 33.08
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.